Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,772 signal articles · 346 in last 24h · 113,134 total before filter · latest 1h ago
346last 24h
2045last 7d
342● bullish (7d)
174● bearish (7d)
204publishers
AllMacro319Earnings1115M&A93Regulatory23Product17Analyst21
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
The Trade Desk crash exposed a much bigger problem
TheStreet3d agobearish
The Trade Desk crash exposed a much bigger problem

The Trade Desk (TTD) has reported the kind of profits that could shift how Wall Street values a growth stock permanently. The digital-advertising company’s shares plunged roughly 22% on Aug. 7, according to Barron's, falling to their lowest level since January 2019 and becoming the S&P 500’s ...

What forward P/E says about the market
Yahoo Finance Video3d agoneutralVIDEO
What forward P/E says about the market

Yahoo Finance's Jared Blikre welcomes Ritholtz Wealth Management data research associate Matt Cerminaro to break down the relationship between the S&P 500 (^GSPC) and its forward price-to-earnings (P/E) ratio, and what current valuations could signal for the market.

It Isn’t Too Late to Buy AI Hardware Boom, Analyst Says. Just Look at HPE Stock.
Barrons.com3d agobullish
It Isn’t Too Late to Buy AI Hardware Boom, Analyst Says. Just Look at HPE Stock.

Hewlett Packard Enterprise has benefited greatly from the massive demand for the hardware needed to power artificial intelligence, and Morgan Stanley doesn’t think the demand will slow down soon. Morgan Stanley analyst Erik Woodring upgraded shares of HPE to Overweight from Equal-Weight on Monday while raising his price target to $71 from $69. The upgrade comes after HPE shares have soared 130% this year and 169% over the past 12 months.

2 Services Stocks for Long-Term Investors and 1 We Find Risky
StockStory3d agoneutral
2 Services Stocks for Long-Term Investors and 1 We Find Risky

Business services providers use their specialized expertise to help enterprises streamline operations and cut costs. Furthermore, the demand for their offerings is rising as more clients outsource non-core functions, a trend that has enabled the industry to return 16.8% over the past six months. At the same time, the S&P 500 was up 10.9%.

U.S. Stocks Open Flat
The Wall Street Journal3d agoneutral
U.S. Stocks Open Flat

Stocks around the globe kicked off the new trading week on a solid footing. In the U.S., indexes were little changed, as focus remains on economic data and the wind-down of second-quarter earnings season.

1 Healthcare Stock Worth Your Attention and 2 We Ignore
StockStory3d agoneutral
1 Healthcare Stock Worth Your Attention and 2 We Ignore

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over the past six months, topping the S&P 500 by 7.4 percentage points.

1 Software Stock to Own for Decades and 2 We Question
StockStory3d agoneutral
1 Software Stock to Own for Decades and 2 We Question

Software is eating the world, and virtually no business is left untouched by it. The undeniable tailwinds fueling the industry have also led to strong returns for SaaS stocks lately as they’ve gained 30.3% over the past six months, outpacing the S&P 500’s 10.9% rise.

Investing.com3d agobullish
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout

Investing.com - U.S. stock index futures edged higher on Monday, while Dow futures were little changed, as investors scaled back hopes for a breakthrough in the Middle East and looked ahead to key inflation data due later this week for fresh clues on the Federal Reserve’s interest rate path.

3 Beaten-Down Healthcare Stocks to Buy in August
24/7 Wall St.3d agobullish
3 Beaten-Down Healthcare Stocks to Buy in August

Healthcare just posted the best three-month run of any S&P 500 sector, yet two of the three biggest pharma names by market cap are still trailing the broader market. That gap between performance and fundamentals is creating a window that income and growth investors rarely see at the mega-cap level.